89 results
8-K
CHRS
Coherus Biosciences Inc
5 Jun 24
Departure of Directors or Certain Officers
9:11am
of stockholders or until her successor is duly elected and qualified, subject to her earlier death, resignation or removal. Ms. Karachun has also been
8-K/A
EX-10.1
CHRS
Coherus Biosciences Inc
21 May 24
Financial Statements and Exhibits
5:14pm
or as a result of the termination, death or disability of such employee, director, manager or consultant.
“Dollars,” “dollars” or use of the sign
8-K
jeo3ob xz
22 Feb 24
Departure of Directors or Certain Officers
4:59pm
8-K
EX-99.1
peh2v
27 Oct 23
Regulation FD Disclosure
4:19pm
8-K
EX-99.1
uofzl6
2 Aug 23
Coherus BioSciences Reports Second Quarter 2023 Financial Results and Business Highlights
4:05pm
424B3
7oyaxiyg
26 Jul 23
Prospectus supplement
4:59pm
S-4/A
3yiz24ztg
24 Jul 23
Registration of securities issued in business combination transactions (amended)
4:42pm
8-K
jqrz99q bkdff7mtgxc
20 Jul 23
Departure of Directors or Certain Officers
5:01pm
S-4
qqiu1t1e
7 Jul 23
Registration of securities issued in business combination transactions
5:03pm
425
lwxbr78o4ohdyu
16 Jun 23
Business combination disclosure
8:08am
425
ds3rcxv019l8
16 Jun 23
Business combination disclosure
7:09am
8-K
EX-2.1
0x6iw7h2zrh3gi6ofgkz
16 Jun 23
Coherus to Acquire Surface Oncology
7:06am